A Breakthrough Impact on Cancer and Related Diseases
The standard approaches to chemotherapy have been effective in some cancer patients but significant progress as measured in the extension of lives has been limited. The global scientific community is unanimous in its view that a transition to more individualized treatment will be essential to significantly improve patient outcome.
BIOMEDCORE has moved to the forefront of this transition by working in concert with the National Research Council of Canada (NRC) and by producing a breakthrough live 3D tumor model. This platform enables oncologists to validate the efficacy of specific drugs on specific patients within two weeks of diagnosis and to recommend interdisciplinary therapies with unprecedented confidence and certainty.
In turn BIOMEDCORE is becoming an industry resource for validating efficacy. This has been made possible through a knowledge-sharing alliance with SUNTRITION - Canada's recognized leader of advanced nutraceutical manufacturing. This relationship has spawned The Coalition for Medicinal Validation and Certification supported by the NRC and comprised of high impact professionals in the world of healthcare and health & welness.
Diagnostic Platform Works Within the Healthcare System
BIOMEDCORE's live 3D tumor model is based on the premise that every tumor is unique and that more timely intervention is crucial; not just in the context of expediting treatment but in the timely and more precise sequencing of protocol choices including chemotherapy. The platform introduces real-time visualization, ease of genetic manipulation and more comprehensive throughput analysis. In effect, it provides oncologists with an opportunity to deliver a more individuallized and interdisciplinary treatment within the framework of established and proven medical practices. It has been created and conceptualized within the robustness of already proven science. This innovation is a leap forward with the potential to redefine success in the treatment of cancer. Perhaps most importantly, it provides oncologists with more comprehensive data faster and more cost effectively than diagnostic tools that are currently available.
Conditions Related to Cancer
Other inflammatory conditions can make people prone to cancer. Examples: Allergy, Diabetes, and Obesity. The 3D tumor Cancer Model (CancerZ) can be applied to other conditions that may be underlying root causes of cancer in specific patients. The NRC has been working closely with BIOMEDCORE to advance an Allergy Model (AllerZ). Inaddition there is a Diabetes Model (Zbetic) underway which is aimed at breakthroughs of Diabetes while an Obesity Model (ObeZ) is setting its sites on Obesity.
Features of the Technology
Individualizing treatment: Enables individualized drug sensitivity analysis prior to patient enrollment
Validating before administration: Simultaneous testing of multiple therapy regimens to accomodate alternative approaches and patient choice
Enabling: A high quality biopsy can create representative CancerZTM facilitating studies on metastasized tumors.
Ensuring safety: Simultaneous prediction of toxicity of drugs and combination drug interactions for better management of treatment side effects
Accelerating innovation: Creating opportunity for strategic and cross-disciplinary collaborations to accelerate translational breakthroughs
- Immune competent: Mimics an individual's active immune system
- Metastasis: Visualizes and predicts patient specific disease patterns
- Rapid stage-matched intervention: Enables timely and individualized attention
BIOMEDCORE scores a first!
WEtech Alliance announces that BIOMEDCORE has been chosen to participate in VentureStart
Read More [+]
Junk DNA controlling oncogenesis
New master switches in unexpected places that control expression of cancer linked genes.
Read More [+]